Trial intelligence / Profile preview

IR-led Deep Sedation for Interventional Radiology Procedures

NCT07443254Phase 2Recruiting

Sponsor
CAMC Health System
Start
Mar 2026
Primary completion
Apr 2027
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ketamine in sedation, sponsored by CAMC Health System. Started Mar 2026; status: recruiting.

02

Drugs

ketamine
03

Conditions

sedation

Beyond the preview

Go deeper on NCT07443254.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07443254.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call